| Prev Close | 622.45 |
| Day Low/High | 604.00 / 632.84 |
| 52 Wk Low/High | 443.14 / 706.95 |
IDEXX Laboratories, Inc. (IDXX)
607.52
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 84.79B |
| Market Cap | 52.78B |
| P/E Ratio | 85.86 |
| Div & Yield | N.A. (N.A) |
Latest News
Are These 2 Stocks Going to the Dogs?
Let's check on the charts of IDEXX Laboratories and Zoetis.
These 2 Companies Could Be More Than Pet Projects for Investors
IDEXX Laboratories and Zoetis Inc. appear ready to trade higher, offering stable opportunities as the dog-eat-dog trade war lingers on.
Putting IDEXX Laboratories Stock Under the Microscope
After the recent decline, let's see what the charts look like and if there are any signals.
IDEXX Laboratories Is Not Responding to Bullish News
Let's review all our charts and indicators.
IDEXX Laboratories Has Been a Real Keeper But a Correction Could Be Coming
Let's check the indicators and charts.
Jim Cramer: 4 Pet-Related Stocks That Are Top Dog
The humanization of pets theme is driving outstanding earnings and share price growth for these 4 names.
Jim Cramer: Follow the Bouncing Equities
Markets start day with a bungee jump.
Cramer: What Stocks Are On a Mission Right Now?
They are objects that once in motion, stay in motion.
Meet TheStreet's Pets! They May Be Expensive -- But We Love Them!
Meet TheStreet's favorite pets! We love them, but let's be real, they get expensive too. But even after all we spend year-round -- and wait until you hear how much that is -- you know we're still going to make sure there are presents under the tree. Watch our video now!
Cramer: Brand Loyalty Between Generations Is Dying
There's a reason to keep coming back to Apple, Facebook, Amazon, Alphabet and Netflix.
The Humanization of Pets Has Changed the Industry -- Here's the Best Stock Pick
Idexx Labs is changing the game and capitalizing on the deep love and affection we share for those furry, four-legged friends.
These 'Rocket Stocks' Look Ready for Blastoff
These four stocks are showing short-term gain catalysts and longer-term growth potential.
Cramer: Reward vs. Political Risk
Trump has made it harder to decide how much volatility you can stand.
Cramer: Barking Up the Right Tree With Pet Health Stocks
The Mars-VCA deal is yet another sign that pet health is a robust business.
Jim Cramer on the Mars Deal for VCA
Jim Cramer says the deal between Mars and VCA is another example of how pet pampering is becoming big business.
Pets Are Family Now and These Stocks Are Best in Show
The humanization of pets has sent spending soaring, which has some pet-related stock seeing major benefits.
Has IDEXX Labs Hit an Exhaustion Gap?
It's best to stay nimble with this one.
Cramer: Here's What to Embrace and What to Shun
With enough of earnings season now under our belt, we check out the promising themes and the sectors to avoid.
IDEXX Labs Looks Set to Climb to $100
Because it was in a $20 consolidation pattern, we should have a decent move.
Paying Up for Quality
For most investors, this simple strategy is the way to go.
Spending On Pets Still Strong, Says Heska CEO
Dr. Robert Grieve, CEO of Heska Corp., says Americans continue to spend on their pets welfare despite the slow economy.
